<ddi:DDIInstance xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:instance:3_3 http://ddialliance.org/Specification/DDI-Lifecycle/3.3/XMLSchema/instance.xsd" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ddi="ddi:instance:3_3" xmlns:r="ddi:reusable:3_3" xmlns:s="ddi:studyunit:3_3" xmlns:d="ddi:datacollection:3_3" xmlns:a="ddi:archive:3_3" xmlns:c="ddi:conceptualcomponent:3_3" xmlns:cm="ddi:comparative:3_3" xmlns:g="ddi:group:3_3" xmlns:l="ddi:logicalproduct:3_3" xmlns:p="ddi:physicaldataproduct:3_3" xmlns:pi="ddi:physicalinstance:3_3" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace" isMaintainable="true" scopeOfUniqueness="Agency">
  <r:URN>urn:ddi:se.researchdata:2023-251:1</r:URN>
  <r:Agency>SND</r:Agency>
  <r:ID>2023-251</r:ID>
  <r:Version>1</r:Version>
  <g:ResourcePackage>
    <r:URN>urn:ddi:se.researchdata:2023-251.ResourcePackage:2.0</r:URN>
    <r:OtherMaterialScheme>
      <r:URN>urn:ddi:se.researchdata:2023-251.OtherMaterialScheme:2.0</r:URN>
    </r:OtherMaterialScheme>
    <a:OrganizationScheme>
      <r:URN>urn:ddi:se.researchdata:2023-251.OrganizationScheme-0:2.0</r:URN>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:2023-251.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Institute of Clinical Sciences, University of Gothenburg</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Anna</a:FirstGiven>
            <a:LastFamily>Corderfeldt Keiller</a:LastFamily>
            <a:FullName>
              <r:String>Anna Corderfeldt Keiller</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0002-1155-3917</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
    </a:OrganizationScheme>
  </g:ResourcePackage>
  <s:StudyUnit>
    <r:URN>urn:ddi:se.researchdata:2023-251.StudyUnit:2.0</r:URN>
    <r:UserID typeOfUserID="datasetIdentifier">2023-251</r:UserID>
    <r:Citation>
      <r:Title>
        <r:String xml:lang="sv">Neurofilament Light som biomarkör för neurotoxicitet efter isolerad hyperterm perfusion - en prospektiv genomförbarhetsstudie</r:String>
        <r:String xml:lang="en">Neurofilament Light as a biomarker for neurotoxicity after isolated limb perfusion - a prospective feasibility trial</r:String>
      </r:Title>
      <r:Creator>
        <r:CreatorReference>
          <r:URN>urn:ddi:se.researchdata:2023-251.Individual-0:2.0</r:URN>
          <r:TypeOfObject>Individual</r:TypeOfObject>
        </r:CreatorReference>
      </r:Creator>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Göteborgs universitet</r:String>
          <r:String xml:lang="en">University of Gothenburg</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Göteborgs universitet</r:String>
          <r:String xml:lang="en">University of Gothenburg</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:PublicationDate>
        <r:SimpleDate>2024-09-09</r:SimpleDate>
      </r:PublicationDate>
      <r:InternationalIdentifier>
        <r:IdentifierContent>10.5878/ykq2-1r07</r:IdentifierContent>
        <r:ManagingAgency controlledVocabularyAgencyName="DOI">DOI</r:ManagingAgency>
      </r:InternationalIdentifier>
    </r:Citation>
    <r:Abstract>
      <r:Content xml:lang="sv">Explorativ feasability-studie där patienter som genomgår isolerad hyperterm perfusion har inkluderats och blodprov har tagits och utvärdering av fysioterapeut har gjorts för att undersöka perifer nervskada efter isolerad hyperterm perfusion.

Innehåll:
Mätuppgifter, svar på blodprov, hälsostatus.</r:Content>
      <r:Content xml:lang="en">Explorative feasibility trial where patients scheduled for isolated limb perfusion were included. Blood samples were taken and a physiotherapist examined the patients pre- and post surgery for evaluation of nerve damage post isolated limb perfusion.

Dataset contents:
Measurements, blood samples, health status.</r:Content>
    </r:Abstract>
    <r:Coverage>
      <r:TopicalCoverage>
        <r:URN>urn:ddi:se.researchdata:2023-251.TopicalCoverage:2.0</r:URN>
        <r:Subject xml:lang="en" controlledVocabularyID="Health.SpecificDiseasesDisordersAndMedicalConditions" controlledVocabularyName="CESSDA Topic Classification">Specific diseases, disorders and medical conditions</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="Health.SpecificDiseasesDisordersAndMedicalConditions" controlledVocabularyName="CESSDA Topic Classification">Specifika sjukdomar, störningar och medicinska tillstånd</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30106" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Physiology and Anatomy</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30106" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Fysiologi och anatomi</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30203" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cancer and Oncology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30203" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cancer och onkologi</r:Subject>
        <r:Keyword xml:lang="en" controlledVocabularyID="D009369" controlledVocabularyName="MeSH">Neoplasms</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D009369" controlledVocabularyName="MeSH">Tumörer</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D015415" controlledVocabularyName="MeSH">Biomarkers</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D015415" controlledVocabularyName="MeSH">Biomarkörer</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D005121" controlledVocabularyName="MeSH">Extremities</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D005121" controlledVocabularyName="MeSH">Extremiteter</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D009420" controlledVocabularyName="MeSH">Nervous System</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D009420" controlledVocabularyName="MeSH">Nervsystem</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D010478" controlledVocabularyName="MeSH">Chemotherapy, Cancer, Regional Perfusion</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D010478" controlledVocabularyName="MeSH">Cancerkemoterapi, regional perfusion</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D012878" controlledVocabularyName="MeSH">Skin Neoplasms</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D012878" controlledVocabularyName="MeSH">Hudtumörer</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D016900" controlledVocabularyName="MeSH">Neurofilament Proteins</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D016900" controlledVocabularyName="MeSH">Neurofilamentproteiner</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D020258" controlledVocabularyName="MeSH">Neurotoxicity Syndromes</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D020258" controlledVocabularyName="MeSH">Toxiska nervskador</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D023981" controlledVocabularyName="MeSH">Sarcoma, Myeloid</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D023981" controlledVocabularyName="MeSH">Sarkom, myeloisk</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="C923" controlledVocabularyName="ICD-10">Myeloid sarcoma</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="C923" controlledVocabularyName="ICD-10">Myelosarkom</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="Z089C" controlledVocabularyName="ICD-10">Kontrollundersökning efter behandling för malignt melanom i huden</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="Z089C" controlledVocabularyName="ICD-10">Kontrollundersökning efter behandling för malignt melanom i huden (Fördjupningskod)</r:Keyword>
      </r:TopicalCoverage>
      <r:SpatialCoverage>
        <r:URN>urn:ddi:se.researchdata:2023-251.SpatialCoverage:2.0</r:URN>
        <r:Description>
          <r:Content xml:lang="en">Patients from all over Sweden</r:Content>
        </r:Description>
        <r:CountryCode>SE</r:CountryCode>
      </r:SpatialCoverage>
      <r:TemporalCoverage>
        <r:URN>urn:ddi:se.researchdata:2023-251.TemporalCoverage:2.0</r:URN>
        <r:ReferenceDate>
          <r:StartDate>2019-04-12</r:StartDate>
          <r:EndDate>2020-09-25</r:EndDate>
        </r:ReferenceDate>
      </r:TemporalCoverage>
    </r:Coverage>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">TimeUnit<r:ControlledVocabularyURN>http://rdf-vocabulary.ddialliance.org/cv/AnalysisUnit/2.1.3/8b62b80</r:ControlledVocabularyURN></r:AnalysisUnit>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">EventOrProcessOrActivity<r:ControlledVocabularyURN>http://rdf-vocabulary.ddialliance.org/cv/AnalysisUnit/2.1.3/fa83853</r:ControlledVocabularyURN></r:AnalysisUnit>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">snd.a01</r:AnalysisUnit>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">snd.a02</r:AnalysisUnit>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">Individual<r:ControlledVocabularyURN>http://rdf-vocabulary.ddialliance.org/cv/AnalysisUnit/2.1.3/2dd4472</r:ControlledVocabularyURN></r:AnalysisUnit>
    <r:AnalysisUnitsCovered>
      <r:String xml:lang="en">Individual</r:String>
      <r:String xml:lang="sv">Individ</r:String>
    </r:AnalysisUnitsCovered>
    <d:DataCollection>
      <r:URN>urn:ddi:se.researchdata:2023-251.DataCollection:2.0</r:URN>
      <d:CollectionEvent>
        <r:URN>urn:ddi:se.researchdata:2023-251.CollectionEvent:2.0</r:URN>
        <d:DataCollectorOrganizationReference>
          <r:URN>urn:ddi:se.researchdata:2023-251.Organization-0:2.0</r:URN>
          <d:ID />
          <d:Version />
          <d:TypeOfObject>Organization</d:TypeOfObject>
        </d:DataCollectorOrganizationReference>
        <d:DataCollectionDate>
          <r:StartDate>2019-04-11</r:StartDate>
          <r:EndDate>2020-10-23</r:EndDate>
        </d:DataCollectionDate>
        <d:ModeOfCollection>
          <r:URN>urn:ddi:se.researchdata:2023-251.CollectionEvent-0-ModeOfCollectionType:2.0</r:URN>
          <d:TypeOfModeOfCollection>Measurements and tests</d:TypeOfModeOfCollection>
          <r:Description>
            <r:Content xml:lang="en">Measurements and tests</r:Content>
            <r:Content xml:lang="sv">Mätningar och tester</r:Content>
          </r:Description>
        </d:ModeOfCollection>
      </d:CollectionEvent>
    </d:DataCollection>
    <a:Archive>
      <r:URN>urn:ddi:se.researchdata:2023-251.Archive:2.0</r:URN>
      <a:ArchiveSpecific>
        <a:Item>
          <a:Access>
            <r:URN>urn:ddi:se.researchdata:2023-251.Archive-ArchiveSpecificType-AccessType:2.0</r:URN>
            <a:TypeOfAccess controlledVocabularyName="info:eu-repo-Access-Terms vocabulary">restrictedAccess</a:TypeOfAccess>
          </a:Access>
          <a:DataFileQuantity>9</a:DataFileQuantity>
        </a:Item>
      </a:ArchiveSpecific>
    </a:Archive>
  </s:StudyUnit>
</ddi:DDIInstance>